Butalbital, Aspirin, and Caffeine (Butalbital / Aspirin / Caffeine) - Summary

SUMMARY

Butalbital, Aspirin, and Caffeine Capsules, USP is supplied in capsule form for oral administration. Each capsule contains the following active ingredients:

butalbital, USP. .. .. .. .. .. ..	50 mg
aspirin, USP.. .. .. .. .. .. .. ..	325 mg
caffeine, USP. .. .. .. .. .. .. .	40 mg

Butalbital, Aspirin, and Caffeine Capsules, USP is indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of Butalbital, Aspirin, and Caffeine Capsules, USP in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habit-forming and potentially abusable.

See all Butalbital, Aspirin, and Caffeine indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Butalbital, Aspirin, and Caffeine (Butalbital / Aspirin / Caffeine)

Headaches Quiz: Learn About Headache Pain
Source: MedicineNet Facial Nerve Problems Specialty [2017.09.19]
Title: Headaches Quiz: Learn About Headache Pain
Category: MedicineNet Quiz
Created: 9/28/2010 12:00:00 AM
Last Editorial Review: 9/19/2017 4:58:09 PM

Headache
Source: MedicineNet Anthrax Specialty [2017.08.16]
Title: Headache
Category: Diseases and Conditions
Created: 5/31/2002 12:00:00 AM
Last Editorial Review: 8/16/2017 12:00:00 AM

Migraine vs. Headache: Differences and Similarities
Source: MedicineNet Analgesics, Antipyretics Specialty [2017.06.26]
Title: Migraine vs. Headache: Differences and Similarities
Category: Diseases and Conditions
Created: 6/21/2017 12:00:00 AM
Last Editorial Review: 6/26/2017 12:00:00 AM

Migraine Headache
Source: MedicineNet Antiphospholipid Syndrome Specialty [2017.03.13]
Title: Migraine Headache
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 3/13/2017 12:00:00 AM

Cluster Headaches
Source: MedicineNet Cauliflower Ear Specialty [2016.08.25]
Title: Cluster Headaches
Category: Diseases and Conditions
Created: 2/4/2005 12:00:00 AM
Last Editorial Review: 8/25/2016 12:00:00 AM

more news >>

Published Studies Related to Butalbital, Aspirin, and Caffeine (Butalbital / Aspirin / Caffeine)

Butalbital in the treatment of headache: history, pharmacology, and efficacy. [2001.11]
Analgesics containing butalbital compounded with aspirin, acetaminophen, and/or caffeine are widely used for the treatment of migraine and tension-type headache. The butalbital-containing compounds are efficacious in placebo-controlled trials among patients with episodic tension-type headaches.Because of concerns about overuse, medication-overuse headache, and withdrawal, their use should be limited and carefully monitored.

A protocol for butalbital, aspirin and caffeine (BAC) detoxification in headache patients. [1990.07]
The abuse of the combination drug containing butalbital 50 mg, aspirin 325 mg and caffeine 40 mg (or BAC), is commonly recognized by headache specialists as causing headaches. Despite this widespread problem, there is not a published treatment regimen for the BAC detoxification of patients.The other two patients were still BAC free 18 and 14 months after detoxification.

more studies >>

Clinical Trials Related to Butalbital, Aspirin, and Caffeine (Butalbital / Aspirin / Caffeine)

Metabolomic Fingerprint After Bariatric Surgery [Completed]
Background: Obesity is associated with multiple diseases. Bariatric surgery is the most effective therapy for severe obesity that cannot only reduce body weight but also obesity-associated morbidity. Objective: The metabolic alterations associated with obesity and respective changes after bariatric surgery are incompletely understood. Design: In the longitudinal observational study, the investigator applied a 1H-NMR-based global, untargeted metabolomics strategy on human serum samples that were collected before and repeatedly up to one year after distinct bariatric procedures (sleeve gastrectomy, proximal and distal Roux-en Y gastric bypass; RYGB). For comparison, the investigator also analyzed serum samples from normal-weight and less obesity obese subjects that were matched for 1-year postoperative BMI values of the surgical groups.

more trials >>